The predictive value of a positive phase 2 ASH abstract for peer-reviewed publication and progression to phase 3.

Cucchi, David G J; Polak, Tobias B; Ossenkoppele, Gert J; Rowe, Jacob M; Estey, Elihu H

Cucchi, David G J; Polak, Tobias B; Ossenkoppele, Gert J; Rowe, Jacob M; Estey, Elihu H.

Affiliation

Cucchi DGJ; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Polak TB; Department of Internal Medicine, Franciscus Gasthuis & Vlietland, Rotterdam, The Netherlands.
Ossenkoppele GJ; Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Rowe JM; Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Estey EH; Shaare Zedek Medical Center, Jerusalem, Israel; and.

Blood ; 139(12): 1920-1923, 2022 03 24.

Article in En | MEDLINE | ID: mdl-35020824

Subject(s)

Publishing; Societies, Medical

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Publishing / Societies, Medical Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Blood Year: 2022 Document type: Article Affiliation country: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google